Interestingly, previous studies have demonstrated that HE4 plays a significant role in the fibrotic progression of various non-malignant diseases, including renal fibrosis, pulmonary fibrosis, and dilated cardiomyopathy [29–31]. Here, WFDC2 is linked to pulmonary fibrosis.